Ambrx Biopharma Inc - ESG Rating & Company Profile powered by AI
This Disclosure score includes seventeen UN Sustainable Development Goals including: 'No Poverty', 'Reduced Inequalities' and 'Life below Water'. Alternative corporations in the scoring peer group for Ambrx Biopharma Inc are displayedin the table. If you are employed by Ambrx Biopharma Inc and you would like to use your ESG rating, please contact us.
Ambrx Biopharma Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 0.5; made up of an environmental score of 0.0, social score of 1.6 and governance score of 0.0.
0.5
Low ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| ... | ... | ... | |
| 1898 | Zota Health Care Ltd | 0.7 | Low |
| 1898 | cbdMD Inc | 0.7 | Low |
| 1924 | Ambrx Biopharma Inc | 0.5 | Low |
| 1924 | Beximco Pharmaceuticals Ltd | 0.5 | Low |
| 1924 | Acucela Inc | 0.5 | Low |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Ambrx Biopharma Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Ambrx Biopharma Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes Ambrx Biopharma Inc report the average age of the workforce?
Sign up for free to unlockDoes Ambrx Biopharma Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Ambrx Biopharma Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes Ambrx Biopharma Inc disclose cybersecurity risks?
Sign up for free to unlockDoes Ambrx Biopharma Inc offer flexible work?
Sign up for free to unlockDoes Ambrx Biopharma Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Ambrx Biopharma Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Ambrx Biopharma Inc conduct supply chain audits?
Sign up for free to unlockDoes Ambrx Biopharma Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Ambrx Biopharma Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes Ambrx Biopharma Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes Ambrx Biopharma Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Ambrx Biopharma Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Ambrx Biopharma Inc disclose water use targets?
Sign up for free to unlockDoes Ambrx Biopharma Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid Ambrx Biopharma Inc have a product recall in the last two years?
Sign up for free to unlockDoes Ambrx Biopharma Inc disclose incidents of discrimination?
Sign up for free to unlockDoes Ambrx Biopharma Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Ambrx Biopharma Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Ambrx Biopharma Inc disclose parental leave metrics?
Sign up for free to unlockDoes Ambrx Biopharma Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Ambrx Biopharma Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Ambrx Biopharma Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes Ambrx Biopharma Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Ambrx Biopharma Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Ambrx Biopharma Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Ambrx Biopharma Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes Ambrx Biopharma Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Ambrx Biopharma Inc disclose its waste policy?
Sign up for free to unlockDoes Ambrx Biopharma Inc report according to TCFD requirements?
Sign up for free to unlockDoes Ambrx Biopharma Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Ambrx Biopharma Inc disclose energy use targets?
Sign up for free to unlockDoes Ambrx Biopharma Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Ambrx Biopharma Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Ambrx Biopharma Inc
These potential risks are based on the size, segment and geographies of the company.
Ambrx Biopharma Inc., a clinical-stage biologics company, discovers and develops engineered precision biologics using its proprietary expanded genetic code technology platform. Its lead product candidate is ARX788, an anti-HER2 antibody-drug conjugate (ADC), which is investigated in various clinical trials for the treatment of breast cancer, gastric/gastroesophageal junction cancer, and other solid tumors, including ongoing Phase 2/3 clinical trials for the treatment of HER2-positive metastatic breast cancer and gastric cancer. The company is also developing two earlier-stage product candidates, including ARX517, an anti-PSMA ADC, which is in a Phase 1 clinical trial for the treatment of prostate cancer and other solid tumors; and ARX305, an anti-CD70 ADC in investigational new drug-enabling studies for the treatment of renal cell carcinoma and other cancers. In addition, it is developing other multiple product candidates targeting immuno-oncology applications, which include ARX822, a fab-small molecule bispecific that is in preclinical development for cancers; and ARX102, an immuno-oncology IL-2 pathway agonist to stimulate the patient's own immune system by targeting the ß and gamma receptors on the cytotoxic T cell. Ambrx Biopharma Inc. has collaborations with Bristol Myers Squibb Company; AbbVie Inc.; BeiGene; Sino Biopharmaceutical Co., Ltd.; NovoCodex; and Elanco Animal Health. The company was incorporated in 2003 and is headquartered in La Jolla, California.